Navigation Links
Boston Scientific Announces Results for Third Quarter Ended September 30, 2009
Date:10/19/2009

titure- and litigation-related charges, or restructuring and restructuring-related costs. These adjustments do not reflect expected on-going operating results. Accordingly, management excluded these amounts for purposes of calculating these non-GAAP measures to facilitate an evaluation of the Company's current operating performance and for comparison to the Company's past operating performance.
  • Amortization expense - Amortization expense is a non-cash charge and does not impact the Company's liquidity or compliance with the covenants included in its debt agreements. Management removes the impact of amortization from the Company's operating performance to assist in assessing the Company's cash generated from operations. Management believes this is a critical metric for the Company in measuring the Company's ability to generate cash and pay down debt. Therefore, amortization expense is excluded from management's assessment of operating performance and is also excluded from the measures management uses to set employee compensation. Accordingly, management believes this may be useful information to users of its financial statements and therefore has excluded amortization expense for purposes of calculating these non-GAAP measures to facilitate an evaluation of the Company's current operating performance, particularly in terms of liquidity.
  • Foreign exchange on net sales - The impact of foreign exchange is highly variable and difficult to predict. Accordingly, management excludes the impact of foreign exchange for purposes of reviewing regional and divisional revenue growth rates to facilitate an evaluation of the Company's current operating performance and comparison to the Company's past operating performance.

Material Limitations Associated with the Use of Non-GAAP Financial Measures

Non-GAAP net income, non-GAAP net income per diluted share, and regional and div
'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29

Related medicine technology :

1. Boston Scientific to Webcast Conference Call Discussing Third Quarter Financial Results
2. Boston Scientific Announces FDA Clearance and U.S. and European Availability of WallFlex(R) Biliary RX Covered Stents
3. Boston Business Journal Names NxStage(R) Medical Third Fastest Growing Company in Massachusetts
4. Boston Scientific and Johnson & Johnson Announce Settlement of Patent Disputes
5. The 60th Annual Meeting of the American Association for the Study of Liver Diseases Boston, MA -- Hynes Convention Center October 31 -- November 3, 2009
6. SPIRIT IV Results Reaffirm Strong Performance of Boston Scientific PROMUS(R) and TAXUS(R) Express(R) Stents
7. Boston Scientific Announces Schedule for European Society of Cardiology Congress
8. Boston Scientific Welcomes Results of Brain Aneurysm Clinical Trial
9. Boston Scientific Begins Clinical Trial for Next-Generation Nitinol Stent to Treat Iliac Artery Disease
10. Boston Scientific Launches Third-Generation Platinum Chromium Drug-Eluting Stent
11. Boston Scientific Data Show Real-World Survival Rates for Implantable Cardiac Device Patients Exceed Rates From Clinical Trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... N.J. , July 1, 2015  Echo ... device company focused on non-invasive continuous glucose monitoring ... its new and completely re-designed corporate website ... intuitive access to Echo,s technology and enhances the ... The new website better communicates to prospective customers ...
(Date:7/1/2015)... HEIGHTS, Utah , July 1, 2015 /PRNewswire/ ... ), a manufacturer and marketer of rehabilitation and ... completed its $4,025,000 private placement financing led by ... strategic private equity investor focused on the healthcare ... to promote organic growth and pursue potential strategic ...
(Date:7/1/2015)... , July 1, 2015 ExeGi Pharma, ... and probiotic treatments, announced today that it has been ... and Non-prescription Health Products Directorate (NNHPD) to sell Visbiome™ ... Visbiome was developed by Professor Claudio De Simone ... extensive clinical investigation. Professor De Simone recently signed an ...
Breaking Medicine Technology:Echo Therapeutics Announces New Website Launch 2Echo Therapeutics Announces New Website Launch 3Dynatronics Announces Completion Of $4,025,000 Private Placement Led By Prettybrook Partners 2Dynatronics Announces Completion Of $4,025,000 Private Placement Led By Prettybrook Partners 3ExeGi Pharma Secures Canadian Approval For Well Studied Probiotic 2ExeGi Pharma Secures Canadian Approval For Well Studied Probiotic 3
... 2011 ImaginAb, Inc. and Eurogentec S.A. announce ... for producing engineered antibody fragments. The two companies ... high-performance Pichia pastoris expression system. Leveraging ... the collaboration will accelerate the development of ImaginAb,s ...
... Jan. 31, 2011 Global Real Estate Consultants has ... a new facility in Fremont. Global ... provide insight and transparency in the Fremont commercial real ... Inc,s 350,000 sq. ft. state-of-the-art manufacturing facility with pilot ...
Cached Medicine Technology:ImaginAb, Inc. and Eurogentec S.A. Collaborate to Produce Antibody Fragments in Pichia 2Boehringer Ingelheim to Purchase Amgen's Fremont (USA) Facility 2
(Date:7/1/2015)... ... ... Incentivizing the use of generic drugs has been an easy way for plans ... off the prices for the brand-name products. But now that generics are experiencing record ... these high-cost generic drugs. The July issue of Atlantic Information Services, Inc.’s (AIS) The ...
(Date:7/1/2015)... ... July 01, 2015 , ... The Recovery Workforce Summit: 2015 PRA Annual ... editor of The Atlantic, as a keynote on June 2nd in Philadelphia, PA. Stossel ... his personal story added power and reach to the essential message, while opening doors ...
(Date:7/1/2015)... ... 01, 2015 , ... The executive team from Nutritional Products ... number of nutritional and beauty products, announced the company was successful in forging ... Sports Nutrition conference in Tampa, Florida. This specific ECRM trade show gives companies ...
(Date:7/1/2015)... (PRWEB) , ... July 01, 2015 , ... The Thule ... case was relentlessly tested to ensure it lived up to Thule’s rigorous standards. Due ... the protection and quality Thule owners have come to expect. , The ...
(Date:7/1/2015)... ... 2015 , ... AvePoint, the established leader in ... new operational office in Zurich, Switzerland. The new facility will deliver enterprise-level Microsoft ... for organizations throughout the Swiss market. , “AvePoint is committed to addressing ...
Breaking Medicine News(10 mins):Health News:Blues Execs Share Strategies for Managing Generic Drug Inflation in AIS Newsletter 2Health News:Blues Execs Share Strategies for Managing Generic Drug Inflation in AIS Newsletter 3Health News:Scott Stossel, Editor of The Atlantic, Addressed Mental Health Professionals on Reducing Prejudice and Discrimination 2Health News:Scott Stossel, Editor of The Atlantic, Addressed Mental Health Professionals on Reducing Prejudice and Discrimination 3Health News:Scott Stossel, Editor of The Atlantic, Addressed Mental Health Professionals on Reducing Prejudice and Discrimination 4Health News:Scott Stossel, Editor of The Atlantic, Addressed Mental Health Professionals on Reducing Prejudice and Discrimination 5Health News:NPI Executives Report Great Success at ECRM Conference 2Health News:AvePoint Opens Office in Zurich to Meet Increasing Market Demand for Enterprise Collaboration Solutions in Switzerland 2Health News:AvePoint Opens Office in Zurich to Meet Increasing Market Demand for Enterprise Collaboration Solutions in Switzerland 3
... a common cause of death among patients with pneumonia, sepsis ... The damage often occurs suddenly and can cause life-threatening breathing ... treatments. Patients usually are put on ventilators to give their ... doctors can do but wait and hope for the best. ...
... surface, a team of researchers from the University of ... Korean institutions have identified two distinct neuronal signaling pathways ... variety of skin diseases. One pathway produces the therapeutic ... effect. The findings, published in this week,s early ...
... at the University of Utah,s Comprehensive Arrhythmia and Research ... imaging (DE-MRI) holds promise for predicting the risks of ... U.S. Their latest study on a novel application of ... the Journal of the American College of Cardiology ...
... TUESDAY, Feb. 8 (HealthDay News) -- Teens who are already popular ... to bully other kids, new research suggests. The kids seem ... the eyes of their peers, according to the study, published in ... Researchers asked about 3,700 students in 8th, 9th and 10th grades ...
... of health inequalities between socio-economic groups has been noticed ... Organization, the World Bank and the United Nations Development ... importance and made this issue a priority. There is ... but have a particular impact on mental health. A ...
... This release is available in Spanish . ... the Spanish Higher Institute for Scientific Research (CSIC) have ... extensively employed in the development of cosmetic and drug ... of nanotechnology. Phospholipid vesicles (liposomes) are colloidal systems ...
Cached Medicine News:Health News:Gene protects lung from damage due to pneumonia, sepsis, trauma, transplants 2Health News:Gene protects lung from damage due to pneumonia, sepsis, trauma, transplants 3Health News:The hitch in the drug? The itch in the drug 2Health News:Study shows delayed-enhancement MRI may predict, prevent strokes 2Health News:Bullying May Accompany Drive to Be Popular 2Health News:Bullying May Accompany Drive to Be Popular 3Health News:Income inequalities are increasing the occurence of depression during financial crisis 2Health News:New data obtained on liposomes employed in drug encapsulation and gene therapies 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: